Author:
DeMaria A.,McCabe W. R.,Klein J. O.,McCabe W. R.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference17 articles.
1. Neu, H. C., Aswapokee, N., Fu K. P., Aswapokee, P. Antibacterial activity of a new 1-oxa-cephalosporin compared with that of other β-lactam compounds. Antimicrob. Agents Chemother. 16 (1979) 141–149.
2. Barza, M., Tally, F. P., Jacobus, N. V., Gorbach, S. L. In vitro activity of LY127935. Antimicrob. Agents Chemother. 16 (19790 287–292.
3. Yoshida, T., Matsuura, S., Mayama, M., Kameda, Y., Kuwahara, S. Moxalactam (6059-S), a novel 1-oxa-β-lactam with an expanded antibacterial spectrum: Laboratory evaluation. Antimicrob. Agents Chemother. 17 (1980) 302–312.
4. Fu, K. P., Neu, H. C. The comparative β-lactamase resistance and inhibitory activity of 1-oxa-cephalosporin, cefoxitin and cefotaxime. J. Antibiot. (Tokyo) 32 (1979) 909–914.
5. Kurihara, J., Matsumoto, K., Uzuka, Y., Shishido, H., Nagatake, T., Yamada, M., Yoshida, T., Oguma, T., Kimura, Y., Tochino, Y. Human pharmacokinetics of 6059-S. In:Nelson, J. D., Grassi, C. (ed.): Current chemotherapy and infectious disease. American Society for Microbiology, Washington, D. C., 1980, pp. 110–111.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献